Smoking Cessation Aids Market Global Analysis & Forecast 2028
Se espera que el mercado de ayudas para dejar de fumar alcance los 64.032,30 millones de dólares en 2028 desde los 23.413,08 millones de dólares en 2021. Se estima que el mercado crecerá con una tasa compuesta anual del 15,5% de 2021 a 2028.
Los factores clave que están impulsando el crecimiento de este mercado de ayudas para dejar de fumar son la creciente adicción al tabaquismo y el aumento del número de campañas para reducir el tabaquismo y la dependencia del tabaco. Sin embargo, es probable que los elevados costos para el desarrollo de terapias de reemplazo de nicotina limiten en cierta medida el crecimiento del mercado en los próximos años.
Perspectivas del mercado
Creciente adicción al tabaquismo
La nicotina es una sustancia altamente adictiva que se encuentra en la planta del tabaco. Se ha demostrado que fumar tabaco es peligroso en todas sus formas, ya que puede provocar enfermedades crónicas, enfermedades prevenibles, muertes y discapacidades. Según la Organización Mundial de la Salud (OMS), los trastornos relacionados con el tabaquismo provocan alrededor de 435.000 muertes al año en los EE. UU., lo que equivale a aproximadamente 1 de cada 5 del total de muertes en el país. Según los Centros para el Control y la Prevención de Enfermedades (CDC), en 2018, casi 40 millones de adultos en EE. UU. fumaron cigarrillos. Además, alrededor de 4,7 millones de estudiantes de secundaria y preparatoria consumieron al menos un producto de tabaco y alrededor de 1.600 jóvenes menores de 18 años en Estados Unidos fumaron sus primeros cigarrillos. Cada año, casi medio millón de pacientes mueren debido a enfermedades causadas por el tabaquismo. El gobierno de Estados Unidos gasta ~225 mil millones de dólares en atención médica para tratar a pacientes que padecen afecciones asociadas al tabaquismo en Estados Unidos. Por lo tanto, la prevalencia del tabaquismo es alta en varios países del mundo.
Personalice la investigación para adaptarla a sus necesidades
Podemos optimizar y adaptar el análisis y el alcance que no se cumplen a través de nuestras ofertas estándar. Esta flexibilidad le ayudará a obtener la información exacta que necesita para la planificación y la toma de decisiones de su negocio.
Mercado de ayudas para dejar de fumar: ideas estratégicas
CAGR (2021 - 2028)15,5%- Tamaño del mercado 2021
US$ 23,41 mil millones - Tamaño del mercado 2028
US$ 64,03 mil millones
Dinámica del mercado
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Jugadores claves . Jugadores principales
- Pfizer Inc.
- GlaxoSmithKline plc.
- Laboratorios del Dr. Reddy
- Johnson y Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
Panorama regional
- América del norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Segmentación de mercado
- Terapia de reemplazo de nicotina
- Drogas
- Cigarrillos electrónicos
- Otros
- Farmacias Hospitalarias
- Canal en línea
- Farmacias minoristas
- Otros usuarios finales
- El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.
El escenario es similar en varios países europeos y asiáticos. Grecia, Bulgaria, Francia y Croacia constituyen las poblaciones de mayor consumo de tabaco en Europa. Según el Instituto de Evaluación y Medición de la Salud, fumar es una adicción muy común en Europa, ya que más del 20% de los adultos mayores de 15 años fuman todos los días. Además, según World Population Review, las tasas de tabaquismo más altas se encuentran en el sudeste asiático y en los Balcanes de Europa. El WPR también sugiere que en varios países del sur y sudeste asiático, las tasas de tabaquismo tienden a ser altas entre los hombres. Por ejemplo, en Indonesia, la tasa de tabaquismo entre los hombres fue del 76,20% en 2018. Por lo tanto, el creciente número de poblaciones de fumadores en todo el mundo impulsa el crecimiento del mercado mundial de ayudas para dejar de fumar.
Información basada en productos
Según el producto, el mercado de ayudas para dejar de fumar se segmenta en terapias de reemplazo de nicotina, medicamentos, cigarrillos electrónicos y otros. Los cigarrillos electrónicos se consideran una alternativa saludable a los cigarrillos de tabaco y se estima que serán el segmento de más rápido crecimiento durante el período previsto. Los cigarrillos electrónicos son una alternativa eficaz para reducir las condiciones de salud asociadas con el tabaco, mientras que las terapias de reemplazo de nicotina funcionan mejor para dejar de fumar. Los cigarrillos electrónicos son una amenaza potencial para los cigarrillos a base de tabaco. Además, el consumo de cigarrillos electrónicos es menos dañino en comparación con los cigarrillos normales, no produce humo ni riesgo de tabaquismo pasivo, se permite su uso incluso en lugares para no fumadores, los niveles variables de nicotina y la disponibilidad en varios sabores son algunos de los principales Factores determinantes para el mercado de los cigarrillos electrónicos. Además, la creciente popularidad de los cigarrillos electrónicos respaldada por su característica electrónica es el factor principal que contribuye a su creciente demanda.
Información basada en el usuario final
Según el usuario final, el mercado de ayudas para dejar de fumar se segmenta en farmacias hospitalarias, canales en línea, farmacias minoristas y otros usuarios finales. Es probable que el segmento de farmacias minoristas tenga la mayor participación del mercado en 2021, sin embargo, se prevé que el segmento del canal en línea registre la CAGR más alta del mercado durante el período de pronóstico.
Los actores clave como Pfizer Inc.; GlaxoSmithKline plc.; Laboratorios del Dr. Reddy; Johnson y Johnson Services, Inc.; Cipla Inc.; Perrigo Company plc; Bausch Health Companies Inc.; Glenmark; NJOY; y Juul Labs adoptan varias estrategias orgánicas e inorgánicas para mejorar sus ingresos y su posición en el mercado. Por ejemplo, en julio de 2020, Dr Reddy's Laboratories lanzó al mercado estadounidense pastillas de nicotina Polacrilex de venta libre en concentraciones de 2 mg y 4 mg. Además, en noviembre de 2020, Perrigo Company plc completó el cuarto año de su campaña “Dejar de fumar es mejor” en asociación con la Sociedad Estadounidense del Cáncer (ACS).
Alcance del informe de mercado de Ayudas para dejar de fumar
Atributo del informe | Detalles |
---|---|
Tamaño del mercado en 2021 | 23,41 mil millones de dólares |
Tamaño del mercado para 2028 | 64,03 mil millones de dólares |
CAGR global (2021 - 2028) | 15,5% |
Información histórica | 2019-2020 |
Período de pronóstico | 2022-2028 |
Segmentos cubiertos | Por producto
|
Regiones y países cubiertos | América del norte
|
Líderes del mercado y perfiles clave de empresas |
|
- El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.
Mercado de ayudas para dejar de fumar – por producto
- Terapia de reemplazo de nicotina
- Drogas
- Cigarrillos electrónicos
- Otros
Mercado de ayudas para dejar de fumar – por usuario final
- Farmacias Hospitalarias
- Canal en línea
- Farmacias minoristas
- Otros
Mercado de ayudas para dejar de fumar – por geografía
América del norte
- A NOSOTROS
- Canadá
- México
Europa
- Francia
- Alemania
- Italia
- Reino Unido
- España
- El resto de Europa
Asia Pacífico (APAC)
- Porcelana
- India
- Japón
- Australia
- Corea del Sur
- Resto de Asia Pacífico
Medio Oriente y África (MEA)
- Sudáfrica
- Arabia Saudita
- Emiratos Árabes Unidos
- Resto de Medio Oriente y África
América del Sur y Central (SCAM)
- Brasil
- Argentina
- Resto de América del Sur y Central
Perfiles de empresa
- Pfizer Inc.
- GlaxoSmithKline plc.
- Laboratorios del Dr. Reddy
- Johnson y Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Laboratorios Juul
Smoking Cessation Aids Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 23.41 Billion |
Market Size by | US$ 64.03 Billion |
Global CAGR | 15.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Producto
|
Regions and Countries Covered |
América del Norte
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.
The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.
The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.
The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.
The List of Companies - Smoking Cessation Aids Market
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.